NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Pharmacologic considerations for Shuttle astronautsMedication usage by crewmembers in the preflight and inflight mission periods is common in the Shuttle Program. The most common medical reports for which medication is used are: space motion sickness (SMS), sleeplessness, headache, and backache. A number of medications are available in the Shuttle Medical Kit to treat these problems. Currently, astronauts test all frequently used medications before mission assignment to identify potential side-effects, problems related to performance, personal likes/dislikes, and individual therapeutic effect. However, microgravity-induced changes in drug pharmacokinetics, in combination with multiple operational factors, may significantly alter crewmember responses inflight. This article discusses those factors that may impact pharmacologic efficacy during Shuttle missions.
Document ID
19930033540
Acquisition Source
Legacy CDMS
Document Type
Reprint (Version printed in journal)
Authors
Santy, Patricia A.
(NASA Johnson Space Center Houston; Texas Univ., Galveston, United States)
Bungo, Michael W.
(NASA Johnson Space Center Houston, TX, United States)
Date Acquired
August 15, 2013
Publication Date
October 1, 1991
Publication Information
Publication: Journal of Clinical Pharmacology
Volume: 31
Issue: 10
ISSN: 0091-2700
Subject Category
Aerospace Medicine
Accession Number
93A17537
Distribution Limits
Public
Copyright
Other

Available Downloads

There are no available downloads for this record.
No Preview Available